These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
275 related items for PubMed ID: 22634340
1. Association of the IL28B genotype with insulin resistance in patients with chronic hepatitis C. Stättermayer AF, Rutter K, Beinhardt S, Scherzer TM, Stadlmayr A, Hofer H, Wrba F, Steindl-Munda P, Krebs M, Datz C, Trauner M, Ferenci P. J Hepatol; 2012 Sep; 57(3):492-8. PubMed ID: 22634340 [Abstract] [Full Text] [Related]
2. Insulin resistance predicts sustained virological response to treatment of chronic hepatitis C independently of the IL28b rs12979860 polymorphism. Del Campo JA, Ampuero J, Rojas L, Conde M, Rojas A, Maraver M, Millán R, García-Valdecasas M, García-Lozano JR, González-Escribano MF, Romero-Gómez M. Aliment Pharmacol Ther; 2013 Jan; 37(1):74-80. PubMed ID: 23121166 [Abstract] [Full Text] [Related]
3. TM6SF2 rs58542926 is not associated with steatosis and fibrosis in large cohort of patients with genotype 1 chronic hepatitis C. Petta S, Maida M, Grimaudo S, Pipitone RM, Macaluso FS, Cabibi D, Cammà C, Di Marco V, Sferrazza S, Craxì A. Liver Int; 2016 Feb; 36(2):198-204. PubMed ID: 26259026 [Abstract] [Full Text] [Related]
4. Implications of PNPLA3 polymorphism in chronic hepatitis C patients receiving peginterferon plus ribavirin. Valenti L, Aghemo A, Stättermayer AF, Maggioni P, De Nicola S, Motta BM, Rumi MG, Dongiovanni P, Ferenci P, Colombo M, Fargion S. Aliment Pharmacol Ther; 2012 Jun; 35(12):1434-42. PubMed ID: 22530607 [Abstract] [Full Text] [Related]
5. The rs738409 polymorphism of the PNPLA3 gene is associated with hepatic steatosis and fibrosis in Brazilian patients with chronic hepatitis C. Manchiero C, Nunes AKDS, Magri MC, Dantas BP, Mazza CC, Barone AA, Tengan FM. BMC Infect Dis; 2017 Dec 19; 17(1):780. PubMed ID: 29258449 [Abstract] [Full Text] [Related]
6. IL28B and PNPLA3 polymorphisms affect histological liver damage in patients with non-alcoholic fatty liver disease. Petta S, Grimaudo S, Cammà C, Cabibi D, Di Marco V, Licata G, Pipitone RM, Craxì A. J Hepatol; 2012 Jun 19; 56(6):1356-62. PubMed ID: 22314430 [Abstract] [Full Text] [Related]
7. PNPLA3 rs738409 causes steatosis according to viral & IL28B genotypes in hepatitis C. Ampuero J, Del Campo JA, Rojas L, García-Lozano JR, Solá R, Andrade R, Pons JA, Navarro JM, Calleja JL, Buti M, González-Escribano MF, Forns X, Diago M, García-Samaniego J, Romero-Gómez M. Ann Hepatol; 2014 Jun 19; 13(4):356-63. PubMed ID: 24927606 [Abstract] [Full Text] [Related]
8. Effects of IL28B rs12979860 CC genotype on metabolic profile and sustained virologic response in patients with genotype 1 chronic hepatitis C. Petta S, Rosso C, Leung R, Abate ML, Booth D, Salomone F, Gambino R, Rizzetto M, Caviglia P, Smedile A, Grimaudo S, Cammà C, Craxì A, George J, Bugianesi E. Clin Gastroenterol Hepatol; 2013 Mar 19; 11(3):311-7.e1. PubMed ID: 23220171 [Abstract] [Full Text] [Related]
10. Insulin resistance undermines the advantages of IL28B polymorphism in the pegylated interferon alpha-2b and ribavirin treatment of chronic hepatitis C patients with genotype 1. Ogawa E, Furusyo N, Murata M, Ikezaki H, Ihara T, Hayashi T, Toyoda K, Taniai H, Okada K, Kainuma M, Hayashi J. J Hepatol; 2012 Sep 19; 57(3):534-40. PubMed ID: 22613000 [Abstract] [Full Text] [Related]
11. Association between PNPLA3[G]/I148M variant, steatosis and fibrosis stage in hepatitis C virus - genetic matters. Crisan D, Grigorescu M, Crisan N, Craciun R, Lupsor M, Radu C, Grigorescu MD, Suciu A, Epure F, Avram L, Leach N. J Physiol Pharmacol; 2019 Aug 19; 70(4):. PubMed ID: 31642820 [Abstract] [Full Text] [Related]
14. Impact of comorbid hepatic steatosis on treatment of chronic hepatitis C in Japanese patients and the relationship with genetic polymorphism of IL28B, PNPLA3 and LDL receptor. Moritou Y, Ikeda F, Iwasaki Y, Baba N, Takaguchi K, Senoh T, Nagano T, Takeuchi Y, Yasunaka T, Ohnishi H, Miyake Y, Takaki A, Nouso K, Yamamoto K. Acta Med Okayama; 2014 Aug 19; 68(1):17-22. PubMed ID: 24553484 [Abstract] [Full Text] [Related]
15. Genetic Polymorphisms of IL28B and PNPLA3 Are Predictive for HCV Related Rapid Fibrosis Progression and Identify Patients Who Require Urgent Antiviral Treatment with New Regimens. Tamaki N, Kurosaki M, Higuchi M, Takada H, Nakakuki N, Yasui Y, Suzuki S, Tsuchiya K, Nakanishi H, Itakura J, Takahashi Y, Ogawa S, Tanaka Y, Asahina Y, Izumi N. PLoS One; 2015 Aug 19; 10(9):e0137351. PubMed ID: 26352693 [Abstract] [Full Text] [Related]
16. Impact of patatin-like phospholipase-3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C. Trépo E, Pradat P, Potthoff A, Momozawa Y, Quertinmont E, Gustot T, Lemmers A, Berthillon P, Amininejad L, Chevallier M, Schlué J, Kreipe H, Devière J, Manns M, Trépo C, Sninsky J, Wedemeyer H, Franchimont D, Moreno C. Hepatology; 2011 Jul 19; 54(1):60-9. PubMed ID: 21488075 [Abstract] [Full Text] [Related]
20. Association between CXCL10 and DPP4 Gene Polymorphisms and a Complementary Role for Unfavorable IL28B Genotype in Prediction of Treatment Response in Thai Patients with Chronic Hepatitis C Virus Infection. Thanapirom K, Suksawatamnuay S, Sukeepaisarnjaroen W, Tangkijvanich P, Treeprasertsuk S, Thaimai P, Wasitthankasem R, Poovorawan Y, Komolmit P. PLoS One; 2015 Jul 19; 10(9):e0137365. PubMed ID: 26339796 [Abstract] [Full Text] [Related] Page: [Next] [New Search]